Jeff Unger

Summary

Publications

  1. doi request reprint Hypoglycemia in insulin-treated diabetes: a case for increased vigilance
    Jeff Unger
    Catalina Research Institute, Chino, CA 91710, USA
    Postgrad Med 123:81-91. 2011
  2. doi request reprint Rationale use of GLP-1 receptor agonists in patients with type 1 diabetes
    Jeff Unger
    Unger Primary Care, 14726 Ramona Ave, Suite 110, Chino, CA, 91710, USA
    Curr Diab Rep 13:663-8. 2013
  3. ncbi request reprint Clinical efficacy of GLP-1 agonists and their place in the diabetes treatment algorithm
    Jeff Unger
    Catalina Research Institute, Chino, CA 91750 3502, USA
    J Am Osteopath Assoc 111:eS2-9. 2011
  4. pmc Incretins: clinical perspectives, relevance, and applications for the primary care physician in the treatment of patients with type 2 diabetes mellitus
    Jeff Unger
    Catalina Research Institute, 14726 Ramona Ave, Ste 110, Chino, CA 91710, USA
    Mayo Clin Proc 85:S38-49. 2010
  5. ncbi request reprint Liraglutide: can it make a difference in the treatment of type 2 diabetes?
    J Unger
    Catalina Research Institute, Chino, CA 91710, USA
    Int J Clin Pract Suppl . 2010
  6. doi request reprint Type 2 diabetes: an expanded view of pathophysiology and therapy
    Jeff Unger
    Metabolic Studies, Catalina Research Institute, Chino, CA 91710, USA
    Postgrad Med 122:145-57. 2010
  7. doi request reprint Preventing type 2 diabetes
    Jeff Unger
    Catalina Research Institute, 12598 Central Avenue, Chino, CA 91710, USA
    Prim Care 35:645-62. 2008
  8. pmc Comparing the efficacy, safety, and utility of intensive insulin algorithms for a primary care practice
    Jeff Unger
    Catalina Research Institute, 14726 Ramona Ave, Suite 110, Chino, CA, 91710, USA
    Diabetes Ther 2:40-50. 2011
  9. doi request reprint Current strategies for evaluating, monitoring, and treating type 2 diabetes mellitus
    Jeff Unger
    Chino Medical Group Diabetes and Headache Intervention Center, Chino, California 91710, USA
    Am J Med 121:S3-8. 2008
  10. doi request reprint Optimizing insulin therapy for type 2 diabetes mellitus. Introduction
    Jeff Unger
    Chino Medical Group Diabetes and Headache Intervention Center, Chino, California 91710, USA
    Am J Med 121:S1-2. 2008

Detail Information

Publications19

  1. doi request reprint Hypoglycemia in insulin-treated diabetes: a case for increased vigilance
    Jeff Unger
    Catalina Research Institute, Chino, CA 91710, USA
    Postgrad Med 123:81-91. 2011
    ....
  2. doi request reprint Rationale use of GLP-1 receptor agonists in patients with type 1 diabetes
    Jeff Unger
    Unger Primary Care, 14726 Ramona Ave, Suite 110, Chino, CA, 91710, USA
    Curr Diab Rep 13:663-8. 2013
    ..This paper will consider the physiologic and pharmacologic benefits of adding GLP-1 receptor agonists to therapeutic regimens of patients with T1DM. ..
  3. ncbi request reprint Clinical efficacy of GLP-1 agonists and their place in the diabetes treatment algorithm
    Jeff Unger
    Catalina Research Institute, Chino, CA 91750 3502, USA
    J Am Osteopath Assoc 111:eS2-9. 2011
    ..Glucagon-like peptide-1 agonists also have beneficial effects on cardiovascular risk factors such as blood pressure and lipids...
  4. pmc Incretins: clinical perspectives, relevance, and applications for the primary care physician in the treatment of patients with type 2 diabetes mellitus
    Jeff Unger
    Catalina Research Institute, 14726 Ramona Ave, Ste 110, Chino, CA 91710, USA
    Mayo Clin Proc 85:S38-49. 2010
    ..This article provides an overview of the role of incretin-based therapies in the management of patients with type 2 DM and how primary care physicians can incorporate these agents into their practice...
  5. ncbi request reprint Liraglutide: can it make a difference in the treatment of type 2 diabetes?
    J Unger
    Catalina Research Institute, Chino, CA 91710, USA
    Int J Clin Pract Suppl . 2010
    ....
  6. doi request reprint Type 2 diabetes: an expanded view of pathophysiology and therapy
    Jeff Unger
    Metabolic Studies, Catalina Research Institute, Chino, CA 91710, USA
    Postgrad Med 122:145-57. 2010
    ..In general, patients with type 2 diabetes should be treated to their lowest targeted glycemic goals as soon as they are diagnosed, for as long as possible, as safely as possible, and as rationally as possible...
  7. doi request reprint Preventing type 2 diabetes
    Jeff Unger
    Catalina Research Institute, 12598 Central Avenue, Chino, CA 91710, USA
    Prim Care 35:645-62. 2008
    ..Aggressive, timely, and physiologic management of prediabetes should be advocated...
  8. pmc Comparing the efficacy, safety, and utility of intensive insulin algorithms for a primary care practice
    Jeff Unger
    Catalina Research Institute, 14726 Ramona Ave, Suite 110, Chino, CA, 91710, USA
    Diabetes Ther 2:40-50. 2011
    ..This article will discuss ways by which insulin therapies can be effectively introduced to patients within busy primary care practices. Published evidence-based basal insulin protocols will be evaluated for safety and efficacy...
  9. doi request reprint Current strategies for evaluating, monitoring, and treating type 2 diabetes mellitus
    Jeff Unger
    Chino Medical Group Diabetes and Headache Intervention Center, Chino, California 91710, USA
    Am J Med 121:S3-8. 2008
    ....
  10. doi request reprint Optimizing insulin therapy for type 2 diabetes mellitus. Introduction
    Jeff Unger
    Chino Medical Group Diabetes and Headache Intervention Center, Chino, California 91710, USA
    Am J Med 121:S1-2. 2008
  11. ncbi request reprint Fine-tuning glycemic control using computerized downloading software: a case-based approach
    Jeff Unger
    Chino Medical Group, Diabetes and Headache Intervention Center, Chino, California 91710, USA
    Endocrinol Metab Clin North Am 36:27-45. 2007
    ..Incorporating computerized software into our practices so that we are able to fine-tune our prescribed treatments is an inexpensive and efficient way to improve the quality of our patients' lives...
  12. ncbi request reprint Recognition and management of diabetic neuropathy
    Jeff Unger
    Chino Medical Group, Diabetes and Headache Intervention Center, Chino, CA 91710, USA
    Prim Care 34:887-913, viii. 2007
    ..Consequences associated with diabetic neuropathy include nontraumatic amputations and silent ischemia; thus proper foot care and education regarding "warning signs" of silent ischemia are necessary...
  13. ncbi request reprint Management of diabetes in pregnancy, childhood, and adolescence
    Jeff Unger
    Chino Medical Group, Diabetes and Headache Intervention Center, Chino, CA 91710, USA
    Prim Care 34:809-43, vii. 2007
    ..By promoting a healthy lifestyle to high-risk patients, primary care physicians can help delay the onset and reduce the incidence of type 2 diabetes in children and adolescents...
  14. ncbi request reprint Management of type 1 diabetes
    Jeff Unger
    Chino Medical Group, Diabetes and Headache Intervention Center, Chino, CA 91710, USA
    Prim Care 34:791-808, vi-vii. 2007
    ....
  15. ncbi request reprint Diagnosis and management of type 2 diabetes and prediabetes
    Jeff Unger
    Chino Medical Group, Diabetes and Headache Intervention Center, Chino, CA 91710, USA
    Prim Care 34:731-59, vi. 2007
    ....
  16. doi request reprint Recognition, prevention, and proactive management of hypoglycemia in patients with type 1 diabetes mellitus
    Jeff Unger
    Catalina Research Institute, Chino, CA, USA
    Postgrad Med 123:71-80. 2011
    ..This review explores the utility of initiating CGM within the primary care setting for patients at high risk for developing hypoglycemia...
  17. ncbi request reprint Defining the role of incretin mimetic therapy in the management of type 2 diabetes
    Jeff Unger
    Chino Medical Group Diabetes and Headache Intervention Center, Chino, CA USA
    J Fam Pract 56:S4-S10. 2007
    ..This article will evaluate a typical patient case and strategies employed by the patient and health care provider...
  18. ncbi request reprint Migraine headaches: a historical prospective, a glimpse into the future, and migraine epidemiology
    Jeff Unger
    Chino Medical Group Diabetes and Headache Intervention Center, Quadrant Medical Education, CA, USA
    Dis Mon 52:367-84. 2006
  19. ncbi request reprint Why and when to implement incretin therapy
    Jeffrey S Freeman
    Division of Endocrinology and Metabolism, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA
    J Fam Pract 57:S19-25. 2008